SGT大麻素列表
新西蘭的 Stargate International 公司曾在2000年至2010年間設計了一系列合成大麻素[1]，並以公司縮寫"SGT"加編號命名，其中一些是：
列表
[編輯]| 化學結構 | 名稱（別名） | 分子式 | 化學名 | CAS編號 | PubChem CID |
|---|---|---|---|---|---|
| SGT-3 |
C 23H 25NO 2 |
[1-(Cyclohexylmethyl)-1H-indol-3-yl](4-methoxyphenyl)methanone | 1373879-01-6 | ||
|
SGT-4 （CHM-081） |
C 27H 27NO 2 |
[1-(cyclohexylmethyl)indol-3-yl]-(4-methoxynaphthalen-1-yl)methanone | 1373876-34-6 | 118796420 |
| SGT-5 |
C 24H 25N 3O |
3-(3-Benzyl-1,2,4-oxadiazol-5-yl)-1-(cyclohexylmethyl)-1H-indole | 1373879-22-1 | ||
| SGT-6 |
C 21H 26N 2O 2 |
(3-tert-Butyl-1,2-oxazol-5-yl)(1-pentyl-1H-indol-3-yl)methanone | |||
| SGT-7 （ADB-CHMICA、ADMB-CHMICA） |
C 22H 31N 3O 2 |
N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-1-(cyclohexylmethyl)-1H-indole-3-carboxamide | 2460738-56-9 | 125181328 | |
| SGT-9 |
C 26H 30N 2O |
1-(Cyclohexylmethyl)-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]-1H-indole-3-carboxamide1-(Cyclohexylmethyl)-N-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-1H-indole-3-carboxamide | |||
| SGT-10 |
C 25H 28N 2O 2 |
1-(Cyclohexylmethyl)-N-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-1H-indole-3-carboxamide | |||
|
SGT-13 （2F-QMPSB） |
C 22H 20F 2N 2O 4S |
8-quinolinyl 4-methyl-3-[(4,4-difluoropiperidin-1-yl)sulfonyl]benzoate | 2707165-48-6 | 155884739 |
|
SGT-14 （EAM-2201） |
C 26H 26FNO |
(4-Ethyl-1-naphthalenyl)[1-(5-fluoropentyl)-1H-indol-3-yl]-methanone | 1364933-60-7 | 71308187 |
|
SGT-17 （THJ-018） |
C23H22N2O | 1-Naphthalenyl(1-pentyl-1H-indazol-3-yl)-methanone | 1364933-55-0 | 124518671 |
|
SGT-20 （5F-JWH-398） |
C 24H 21ClFNO |
(4-Chloronaphthalen-1-yl)-[1-(5-fluoropentyl)indol-3-yl]methanone | 1391486-12-6 | 125181332 |
|
SGT-21 （PB-22、QUPIC） |
C23H22N2O2 | 1-Pentyl-1H-indole-3-carboxylic acid 8-quinolinyl ester | 1400742-17-7 | 71604304 |
|
SGT-24 （CUMYL-PINACA） |
C22H27N3O | 1-pentyl-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide | 1400742-15-5 | 86273676 |
|
SGT-25 （5F-CUMYL-PINACA） |
C 22H 26FN 3O |
1-(5-Fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide | 1400742-16-6 | 86274158 |
| SGT-28 （(Indazole) MAM-2201） |
C 24H 23FN 2O |
[1-(5-Fluoropentyl)-1H-indazol-3-yl](4-methylnaphthalen-1-yl)methanone | 1400742-01-9 | 170857604 | |
|
SGT-32 （BB-22、QUCHIC） |
C 25H 24N 2O 2 |
1-(cyclohexylmethyl)-1H-indole-3-carboxylic acid 8-quinolinyl ester | 1400742-42-8 | 71711120 |
|
SGT-37 (A-CHMINACA) | C 25H 33N 3O |
N-(1-adamantyl)-1-(cyclohexylmethyl)indazole-3-carboxamide | 1400742-33-7 | 137700313 |
|
SGT-40 （Adamantyl-THPINACA isomer 1） |
C 24H 31N 3O 2 |
N-(1-Adamantyl)-1-(tetrahydropyran-4-ylmethyl)indazole-3-carboxamide | 1400742-48-4 | 129532625 |
|
SGT-42 （CUMYL-THPINACA） |
C 23H 27N 3O 2 |
1-(oxan-4-ylmethyl)-N-(2-phenylpropan-2-yl)indazole-3-carboxamide | 1400742-50-8 | 86273679 |
|
SGT-48 （PTI-1） |
C 21H 29N 3S |
N,N-diethyl-N-((2-(1-pentyl-1H-indol-3-yl)thiazol-4-yl)methyl)ethanamine | 1400742-46-2 | 124037378 |
|
SGT-49 （PTI-2） |
C 23H 33N 3OS |
N-(2-methoxyethyl)-N-((2-(1-pentyl-1H-indol-3-yl)thiazol-4-yl)methyl)propan-2-amine | 1400742-45-1 | 124037377 |
|
SGT-55 （CUMYL-BICA） |
C 22H 26N 2O |
1-butyl-N-(2-phenylpropan-2-yl)-1H-indole-3-carboxamide | 1400742-22-4 | 86273677 |
|
SGT-56 （CUMYL-PICA） |
C 23H 28N 2O |
1-pentyl-N-(2-phenylpropan-2-yl)-1H-indole-3-carboxamide | 1400742-32-6 | 86273678 |
|
SGT-64 （4'F-CUMYL-5F-PICA） |
C 23H 26F 2N 2O |
1-(5-fluoropentyl)-N-[2-(4-fluorophenyl)propan-2-yl]indole-3-carboxamide | 1631074-52-6 | 117650357 |
|
SGT-65 （4'F-CUMYL-5F-PINACA） |
C 22H 25F 2N 3O |
1-(5-fluoropentyl)-N-[2-(4-fluorophenyl)propan-2-yl]indazole-3-carboxamide | 1631074-53-7 | 117650358 |
|
SGT-78 （CUMYL-4CN-BINACA） |
C 22H 24N 4O |
1-(4-Cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide | 1631074-54-8 | 117650402 |
| SGT-80 |
C 23H 28N 2O 2 |
(3-tert-Butyl-1,2-oxazol-5-yl)[1-(cyclohexylmethyl)-1H-indol-3-yl]methanone | |||
| SGT-82 |
C 16H 23N 3O |
1-Pentyl-N-(propan-2-yl)-1H-indazole-3-carboxamide | |||
| SGT-84 |
C 21H 33N 3O |
N-(Octan-2-yl)-1-pentyl-1H-indazole-3-carboxamide | |||
|
SGT-88 （THQ-PINACA） |
C 22H 25N 3O |
3,4-dihydro-2H-quinolin-1-yl-(1-pentylindazol-3-yl)methanone | 2950480-11-0 | 165361626 |
| SGT-89 |
C 25H 31N 3O |
(4-Benzylpiperidin-1-yl)(1-pentyl-1H-indazol-3-yl)methanone | |||
| SGT-90 |
C 24H 29N 3O 2 |
N-[(5-Methoxy-2,3-dihydro-1H-inden-1-yl)methyl]-1-pentyl-1H-indazole-3-carboxamide | |||
| SGT-91 |
C 17H 23FN 2O |
1-(5-Fluoropentyl)-N-propyl-1H-indole-3-carboxamide | |||
| SGT-92 |
C 17H 23FN 2O |
1-(5-Fluoropentyl)-N-(propan-2-yl)-1H-indole-3-carboxamide | |||
| SGT-93 |
C 19H 27FN 2O |
1-(5-Fluoropentyl)-N-pentyl-1H-indole-3-carboxamide | |||
| SGT-110 |
C 23H 33N 3O 2 |
1-(Cyclohexylmethyl)-N-[(2S)-3,3-dimethyl-1-(methylamino)-1-oxobutan-2-yl]-1H-indole-3-carboxamide | |||
|
SGT-149 （CUMYL-FUBINACA） |
C 24H 22FN 3O |
1-[(4-fluorophenyl)methyl]-N-(2-phenylpropan-2-yl)indazole-3-carboxamide | 1631074-58-2 | 117650352 |
|
SGT-151 （CUMYL-PEGACLONE） |
C 25H 28N 2O |
2,5-Dihydro-2-(1-methyl-1-phenylethyl)-5-pentyl-1H-pyrido[4,3-b]indol-1-one | 2160555-55-3 | 134818034 |
|
SGT-152 （CUMYL-NBMINACA） |
C25H29N3O | [1-(bicyclo[2.2.1]heptan-2-yl)methyl]-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide | 1631074-60-6 | 117650372 |
|
SGT-157 （4'Cl-CUMYL-PINACA） |
C 22H 26ClN 3O |
N-[2-(4-chlorophenyl)propan-2-yl]-1-pentylindazole-3-carboxamide | 1631074-65-1 | 86274160 |
|
SGT-194 （Adamantyl-THPINACA isomer 2） |
C 24H 31N 3O 2 |
N-(2-Adamantyl)-1-(tetrahydropyran-4-ylmethyl)indazole-3-carboxamide | 2365471-86-7 | 123132009 |
| SGT-245 |
C 23H 33N 3O 2 |
N-[2-Methyl-1-(pyrrolidin-1-yl)propan-2-yl]-1-[(oxan-4-yl)methyl]-1H-indole-3-carboxamide | 1631075-06-3 | 86273922 | |
|
SGT-263 （5F-CUMYL-P7AICA） |
C 22H 26FN 3O |
1-(5-Fluoropentyl)-N-(2-phenylpropan-2-yl)pyrrolo[2,3-b]pyridine-3-carboxamide | 2171492-36-5 | 129532613 |
|
SGT-270 （CUMYL-CH-MEGACLONE） |
C 27H 30N 2O |
2,5-Dihydro-2-(1-methyl-1-phenylethyl)-5-(cyclohexylmethyl)-1H-pyrido[4,3-b]indol-1-one | 2813950-07-9 | 155884822 |
|
SGT-271 （CUMYL-BC-HPMEGACLONE） |
C 28H 30N 2O |
5-({Bicyclo[2.2.1]heptan-2-yl}methyl)-2-(2-phenylpropan-2-yl)-1H,2H,5H-pyrido[4,3-b]indol-1-one | 163190698 | |
|
SGT-273 （CUMYL-CBMEGACLONE） |
C 25H 26N 2O |
2,5-Dihydro-2-(1-methyl-1-phenylethyl)-5-(cyclobutylmethyl)-1H-pyrido[4,3-b]indol-1-one | 2806439-13-2 | 155884737 |
|
SGT-277 （CUMYL-CBMINACA） |
C 22H 25N 3O |
1-(cyclobutylmethyl)-N-(2-phenylpropan-2-yl)indazole-3-carboxamide | 3001262-62-7 | 155884799 |
|
SGT-280 （CUMYL-CBMICA） |
C 23H 26N 2O |
1-(cyclobutylmethyl)-N-(2-phenylpropan-2-yl)indole-3-carboxamide | 2571070-88-5 | 155884426 |
另見
[編輯]參考文獻
[編輯]- ^ Brandt, Simon D.; Kavanagh, Pierce V.; Westphal, Folker; Dreiseitel, Wolfgang; Dowling, Geraldine; Bowden, Matthew J.; Williamson, James P.B. Synthetic cannabinoid receptor agonists: Analytical profiles and development of QMPSB, QMMSB, QMPCB, 2F-QMPSB, QMiPSB, and SGT-233. Drug Testing and Analysis. 2021, 13 (1): 175–196. PMID 32880103. S2CID 221475328. doi:10.1002/dta.2913
.
